Related Experiment Video

Updated: Aug 30, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Downregulation of the BK channel beta1 subunit in genetic hypertension

Gregory C Amberg1, L Fernando Santana

  • 1Department of Physiology and Biophysics, University of Washington, Box 357290, Seattle, Wash 98195, USA.

Circulation Research
|October 11, 2003
PubMed

Insights

Hypertension impairs vascular smooth muscle function by reducing large-conductance, Ca2+-sensitive K+ (BK) channel activity. Lower expression of the BK channel beta1 subunit decreases channel sensitivity to calcium, contributing to vascular dysfunction.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Hypertension Research

Background:

  • Increased arterial tone in hypertension is linked to vascular smooth muscle dysfunction.
  • Large-conductance, Ca2+-sensitive K+ (BK) channels, activated by Ca2+ sparks, normally oppose vasoconstriction via hyperpolarization.
  • The precise molecular mechanisms of BK channel dysfunction in hypertension remain unclear.

Purpose of the Study:

  • To investigate the function of Ca2+ sparks and BK channels in rat models of borderline and severe hypertension.
  • To determine the role of BK channel subunits in altered channel activity during hypertension.

Main Methods:

  • Electrophysiological recordings of spontaneous BK currents in vascular smooth muscle cells.
  • Measurement of Ca2+ spark properties.
  • Analysis of BK channel subunit expression, focusing on the beta1 subunit.

Main Results:

  • BK channel currents were smaller in Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) compared to normotensive controls.
  • BK channels in WKY and SHR cells exhibited reduced sensitivity to intracellular Ca2+.
  • Decreased expression of the BK channel beta1 subunit was identified as the cause of reduced Ca2+ sensitivity in hypertensive rat models.

Conclusions:

  • Reduced BK channel activity, due to lower beta1 subunit expression, contributes to vascular dysfunction in hypertension.
  • Altered molecular composition of BK channels, specifically the beta1 subunit, is a key factor in the development of hypertension-related vascular changes.
  • These findings highlight BK channel modifications as a fundamental event in hypertension.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Concept Videos

Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...